Lower GH level has been demonstrated to increase obesity (Vijayakumar et al., 2011), while GH treatment can improve DBP, lipid profile, and alleviate central obesity (Johannsson et al., 1997). The gene discussed is GH1; the disease is Abdominal obesity.